Healthcare stocks were higher late Friday afternoon, with the NYSE Healthcare Index rising 1.3% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.
The iShares Biotechnology ETF (IBB) gained 1.5%.
In corporate news, Jupiter Neurosciences (JUNS) shares surged past 16% after it said it priced a direct offering of 307,692 shares for gross proceeds of $2 million.
Johnson & Johnson (JNJ) shares rose 1.3% after the firm said Friday Tecvayli plus daratumumab has been approved by the European Commission to treat adults with relapsed or refractory multiple myeloma.
Arbutus Biopharma (ABUS) shares jumped past 9% after the firm said it plans to launch a tender offer to repurchase up to $230 million of its shares at between $5.00 and $5.75 per share.
Health Catalyst (HCAT) shares fell 4.6% after Canaccord Genuity downgraded the stock to hold from buy and cut its price target to $1.80 from $3.